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Several epidemiological studies have shown that high body weights or high body
mass indices (BMI) are related to a high bone mass, and that decreases in body
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Purpose: The traditional belief that obesity is protective against osteoporosis has
been questioned. Recent epidemiologic studies show that body fat itself may be a
risk factor for osteoporosis and bone fractures. Accumulating evidence suggests that
metabolic syndrome and the individual components of metabolic syndrome such as
hypertension, increased triglycerides, and reduced high-density lipoprotein choles-
terol are also risk factors for low bone mineral density. Using a cross sectional study
design, we evaluated the associations between obesity or metabolic syndrome and
bone mineral density (BMD) or vertebral fracture. Materials and Methods: A total
of 907 postmenopausal healthy female subjects, aged 60-79 years, were recruited
from woman hospitals in Seoul, South Korea. BMD, vetebral fracture, bone
markers, and body composition including body weight, body mass index (BMI),
percentage body fat, and waist circumference were measured. Results: After
adjusting for age, smoking status, alcohol consumption, total calcium intake, and
total energy intake, waist circumference was negatively related to BMD of all sites
(lumbar BMD p = 0.037, all sites of femur BMD p < 0.001) whereas body weight
was still positively related to BMD of all sites (p < 0.001). Percentage body fat and
waist circumference were much higher in the fracture group than the non-fracture
group (p = 0.0383, 0.082 respectively). Serum glucose levels were postively cor-
related to lumbar BMD (p = 0.016), femoral neck BMD (p = 0.0335), and femoral
trochanter BMD (p = 0.0082). Serum high density lipoprotein cholesterol (HDLC)
was positively related to femoral trochanter BMD (p = 0.0366) and was lower in the
control group than the fracture group (p = 0.011). Conclusion: In contrast to the
effect favorable body weight on bone mineral density, high percentage body fat and
waist circumference are related to low BMD and a vertebral fracture. Some com-
ponents of metabolic syndrome were related to BMD and a vertebral fracture.  
Key Words: Obesity, metabolic syndrome, bone mineral density, vertebral fracture
Received: April 27, 2010
Revised: May 27, 2010
Accepted: May 27, 2010
Corresponding author: Dr. Duk-Chul Lee,
Department of Family Medicine, 
Yonsei University College of Medicine, 
250 Seongsan-ro, Seodaemun-gu, 
Seoul 120-753, Korea.
Tel: +82-2-2228-2330, Fax: +82-2-362-6835  
E-mail: faith@yuhs.ac
∙The authors have no financial conflicts of
interest.
© Copyright:
Yonsei University College of Medicine 2010
This is an Open Access article distributed under the
terms of the Creative Commons Attribution Non-
Commercial License (http://creativecommons.org/
licenses/by-nc/3.0) which permits unrestricted non-
commercial use, distribution, and reproduction in any
medium, provided the original work is properly cited.
INTRODUCTIONKyong-Chol Kim, et al.
Yonsei Med J   http://www.eymj.org    Volume 51   Number 6   November 2010 858
weight may cause bone loss.
1-3 The following hypothetical
mechanisms are thought to underlie these epidemiologic
observations. First, it is generally accepted that a higher
body mass results in heavier mechanical loading of bone,
enhancing the differentiation of osteoblasts. Weight gain in
the postmenopausal period results in an increase in the
number of adipocytes, which are important sources of
estrogen derived from aromatization, resulting in increas-
ing a bone mineral density (BMD) in postmenopausal
women.
1,4  Furthermore, the insulin resistance of fat cells
may increase circulating quantities of sex hormones such
as androgens and estrogen, thereby increasing bone mass.
5
However, an opposing theory that fat mass is negatively
related to BMD has been suggested. To evaluate the rela-
tionship between obesity and bone mass, it is necessary to
differentiate between fat body mass and lean body mass.
Zhao, et al.
6 showed that fat mass is negatively related to
bone mass when adjusted for body weight. In another study,
risks of osteoporosis, osteopenia, and non-spine fractures
were significantly elevated in subjects with higher percen-
tages body fat after accounting for body weight.
7 In adoles-
cents and young adults, fat mass adjusted by lean mass had
negative or no associations with bone markers and BMD.
8
There are several possible molecular mechanisms that can
explain these findings. With increasing age, osteoblasts in
the bone marrow are replaced by adipocytes and it is report-
ed that increased bone marrow fat is inversely correlated
with decreased trabecular bone volume.
9,10 In the bone mar-
row, peroxisome proliferator-activated receptor-gamma
(PPAR-γ) stimulates adipocyte differentiation but inhibits
osteoblast development from mesenchymal stem cells.
11 In
vivo, increased PPAR-γ activity leads to bone loss whereas
decreased PPAR-γ activity results in increased bone mass.
12
Two adipokines, leptin and adiponectin, which are derived
from adipocytes, also play critical roles in bone formation
and bone resorption.
13-16
With these backgrounds, we measured different adipo-
sities including body weight, BMI, percentage body, fat
and waist circumference to investigate the relation to BMD
of all sites and vertebral fracture. Further, we observed the
relation between metabolic parameters such as serum tri-
glyceride (TG), high density lipoprotein (HDL), glucose,
blood pressure, and BMD of all sites and vertebral fractures.
Study participants 
Healthy postmenopausal female subjects between the ages
of 60-79 years, who were currently living in the community,
were recruited from the visitors who came to the National
Health Assessment Center in woman hospitals in Seoul,
South Korea for a periodic health check-up. Subjects who
had a history of co-morbidities known to affect bone meta-
bolism such as cancer, inflammatory bowel disease, pitui-
tary diseases, hyperthyroidism, primary hyperparathyroi-
dism, renal failure, rheumatic disease, or adrenal disease
were excluded. Subjects who had used glucocorticoids over
the last five years and any hormone replacement therapy
(HRT) or selective estrogen receptor modulator (SERM),
bisphosphonate, or calcitonin for the past year were also
excluded. Any patient with vertebral fractures due to known
accidental traumas were also excluded. 
Data collection
Body weight (kg), BMI (kg/cm
2), percent body fat (%), and
abdominal circumference (cm) were measured and serum
glucose (mg/dL) to evaluate adiposity, triglyceride (mg/dL),
HDL cholesterol (mg/dL), and low density lipoprotein
(LDL) cholesterol (mg/dL) were measured in fasting blood
samples. Systolic and diastolic blood pressures were mea-
sured by nurses. The definition of metabolic syndrome was
followed by the National Cholesterol Education Program’s
Adult Treatment Panel III (NCEP III) guidelines.
17
Osteoporosis parameters included BMD (g/cm
2) in the
hip and spine, vertebral fractures, urine deoxypyridinoline
(DPD), and serum total osteocalcin (OC). Lateral radio-
graphs of the thoracic and lumbar spine demonstrating the
presence of vertebral fractures were interpreted by radio-
graphic morphometry using Genant’s semi-quantitative
method.
18 BMD determined at the lumbar spine (L2-L4) was
assessed using dual energy X-ray absorptiometry (DEXA).
Lunar (Madison, WI, USA) scanners were used in this
study. Nutritional assessment was performed by dietitians
using a 24 hr diet recall method.
19 From this, we calculated
the status of energy expenditure, total calorie intake, cal-
cium intake, and fat intake.
This study was conducted after approval of all research
procedures by the hospital institutional review board
(IRB). Written informed consent was obtained from all
subjects.
Statistical analysis
Statistical analyses were performed using SAS software
for Windows (v.9.1, Cary, NC, USA). Categorical variables
were summarized using frequencies and percentages,
while continuous variables were summarized using sample
size, mean, median, standard deviation, and minimum and
maximum values. Significance was declared at a two-sided
0.05 level, unless otherwise specified. To adjust for age,
body weight, percentage body fat, smoking status, alcohol
consumption, total energy expenditure, total calcium intake,
and total fat and cholesterol intake, we used a general
linear model for continuous dependent variables (BMD,
MATERIALS AND METHODSbone marker, lipid profile, etc.) and a logistic regression
model for categorical dependent variables (risk of osteopo-
rotic fracture and metabolic syndrome). An association
between the independent variables group and the risk of
osteoporotic fracture and metabolic syndrome was cal-
culated using odds ratios and 95% confidence intervals (CI).
The major characteristics of the 907 subjects are shown in
Table 1. The average age of the recruited patients was
65.18 ± 5.42 years. Among the 907 subjects, 302 (33%)
individuals were overweight and 341 (38%) were obese.
The prevalence of metabolic syndrome was 34%, which is
close to the value of 32.6% reported for the Korean popula-
tion (2005, the Third Korea National Health and Nutrition
Examination Survey, KNHANES III ).
20 The average lum-
bar BMD (L BMD) was 0.84 ± 0.26 g/cm
2, while the aver-
age femoral BMD (neck, trochanter, ward) was 0.67 ± 0.12,
0.54 ± 0.09, and 0.45 ± 0.11 g/cm
2, respectively. Among
the 907 subjects, 44 (5%) individuals had a normal BMD,
350 (38%) were osteopenia, and 513 (56%) were osteopo-
rosis. The prevalence of osteoporotic lumbar fractures was
21% in this study. Because no official statistics for osteo-
porotic vertebral fractures are available for Korea, we were
not able to determine whether this value is representative
of the general Korean population.
A simple correlation analysis revealed that both body
weight (r = 0.2947, p < 0.001) and percentage body fat (r =
0.1935, p < 0.0001) were significantly and positively relat-
ed to lumbar BMD (data not shown). However, waist cir-
cumference was negatively related to the lumbar and all
femur site BMD after adjusting for age, smoking status,
alcohol consumption, total calcium intake, total energy
intake, and body weight (Table 2). Percentage body fat
was also negatively correlated to trochanter BMD but not
to other sites. 
The serum glucose level was postively correlated to lum-
bar BMD (p= 0.016), femoral neck BMD (p= 0.0335), and
femoral trochanter BMD (p = 0.0082). Serum high density
lipoprotein cholesterol (HDLC) was only related to femoral
trochanter BMD (p = 0.0366). Serum TG and systolic
blood pressure (BP) were not related to BMD at any site.
Table 3 demonstrates differences in independent varia-
bles between the fracture and non-fracture groups. The
average age of subjects in the fracture group was higher than
that of the non-fracture group (odds ratio 1.077, 95% CI
1.042-1.114). The average body weights and BMIs of the
two groups were not signifcantly different. However, the
percentage body fat and waist circumference were much
higher in the fracture group than the non-fracture group
(odds ratio 1.064, 95% CI 1.003-1.129, odds ratio 1.043,
95% CI 1.011-1.077, respectively Fig. 1).
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RESULTS
Table 1.Characteristics of the Subjects 
Variables Subgroup Mean ± SD n %
Age (yr) 65.18 ± 5.42
Body fat (%) 34.67 ± 2.95
BMI (kg/cm
2) 24.11 ± 2.68
BMI* Normal 302 33%
Overweight 264 29%
Obesity 341 38%
Waist (cm) 88.89 ± 7.59
Systolic BP (mmHg) 131.4 ± 16.19
TG (mg/dL) 126.89 ± 71.83
HDL (mg/dL) 54.72 ± 13.51
Glucose  (mg/dL) 87.26 ± 18.81
Metabolic Syndrome
Yes 317 34%
No 590 66%
BMD
� Normal 44 5%
Osteopenia 350 38%
Osteopororis 513 56%
Vertebral Yes 189 21%
Fracture No 711 79%
BMI, body mass index; BMD, bone mineral density; HDL, high density lipoprotein; TG, triglyceride; BP, blood pressure.
*Normal, BMI < 23; overweight, 23 ≤ BMI < 25; obese, BMI ≥25. 
�Normal, T score > -1.0; osteopenia, -1.0 ≤T score < -2.5; osteoporosis, T score ≥-2.5.Both obesity and osteoporosis are common diseases that
affect millions of people. In recent decades, the association
between obesity and osteoporosis has been actively inves-
tigated both from an epidemiological standpoint and from
a basic research standpoint, and common pathogenic links
have been proposed.
1-3,6,18 Although it is generally accepted
that obesity has a protective effect on bone tissue, some
studies have revealed the opposite: that obesity is not bene-
ficial or has a negative effect on osteoporosis.
21 The relation-
ship between obesity and osteoporosis varies depending on
how obesity is defined. If obesity is defined on the basis of
BMI or body weight, obesity appears to be a protective fac-
tor against bone mineral loss or vertebral fractures. How-
ever, if obesity is based on the percentage body fat, obesity
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DISCUSSION
Table 3.Metabolic Variables Affecting the Incidence of Osteoporotic Fractures
Variables Fracture Non-fracture OR (95% CI) pvalue
n (%) 189 (21%) 711 (79%)
Wt (kg) 57.47 ± 7.73 57.39 ± 7.04 0.182
BMI (kg/cm
2) 24.58 ± 2.95 24.12 ± 2.78 0.946
Body fat (%) 35.47 ± 4.78 34.55 ± 4.83 0.038
Waist (cm) 90.68 ± 7.37 88.41 ± 8.10 0.008
Glucose (mg/dL) 86.62 ± 19.14 87.47 ± 18.54 0.310
HDLC (mg/dL) 52.14 ± 11.99 55.38 ± 13.74 0.011
TG (mg/dL) 129.44 ± 78.82 126.16 ± 69.11 0.448
Systolic BP 133.34 ± 17.20 130.92 ± 15.90 0.919
Metabolic SD
Yes 77 (24.37%) 239 (75.63%)
No 112 (19.18%) 472 (80.82%) 0.924 (0.570, 1.498) 0.748
BMI, body mass index; HDLC, high density lipoprotein cholesterol; TG, triglyceride; BP, blood pressure.
All variables are adjusted for age, smoking status, alcohol consumption, total calcium intake, total energy expenditure, and total calorie
intake and variable of Wt (kg) is additionally adjusted by body fat (%), whereas variable of body fat (%) and waist (cm) are adjusted by Wt
(kg), respectively.
Table 2.Metabolic Variables Relating to BMD
Lumbar Neck Trochanter Ward
F value pvalue F value pvalue F value pvalue F value pvalue
Wt (kg) 5.53 < 0.001 6.21 < 0.001 7.51 < 0.001 4.91 < 0.001
Body fat (%) - 0.93 0.096 - 0.78 0.432 - 2.31 0.021 - 1.36 0.173
Waist (cm) - 2.09 0.037 - 5.07 < 0.001 - 4.58 < 0.001 - 5.01 < 0.001
Glucose (mg/dL) 2.36 0.016 2.13 0.033 2.65 0.008 1.02 0.309
HDL (mg/dL) 1.57 0.107 1.25 0.212 2.09 0.036 0.73 0.465
TG (mg/dL) 1.98 0.060 - 0.2 0.840 1.03 0.302 - 0.2 0.843
Systolic BP 0.6 0.592 - 0.77 0.438 - 1.45 0.148 - 1.26 0.207
BMD, bone mineral density; HDL, high density lipoprotein; TG, triglyceride; BP, blood pressure.
All variables are adjusted for age, smoking status, alcohol consumption, total calcium intake, total energy expenditure, and total calorie
intake and variable of Wt (kg) is additionally adjusted by body fat (%), whereas variable of body fat (%) and waist (cm) are adjusted by Wt
(kg), respectively.
Fig. 1. Odds ratios of vertebral fractures according to adiposity variables. All
variables are adjusted for age, smoking status, alcohol consumption, total
calcium intake, total energy expenditure, and total calorie intake and variable of
Wt (kg) and BMI are additionally adjusted by body fat (%), whereas variable of
body fat (%) and waist (cm) are adjusted by Wt (kg), respectively. BMI: body
mass indices.
Weight
0.974
(0.938,1.012)
0.999
(0.916, 1.086)
1.064
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1.043
(1.011, 1.077)
BMI % Fat Waist
0.8
1
1.2may be a risk factor for osteoporosis. Our data support that
body weight is positively related with BMD and a protective
factor for vertebral fractures, whereas percentage body fat
and waist circumference are negatively related to BMD
and a risk factor for vertebral fractures. These results are
consistent with those of previous studies in the Chinese
population.
6,7 Some studies have demonstrated that not
only lean mass, but also fat mass contribute positively to
BMD.
22-25 In one study, fat mass appeared to contribute
inversely to BMD at all sites in young men, but was posi-
tively related to BMD at the forearm and calcaneous in older
men.
22 However, the authors of this study did not adjust for
body weight when calculating the effect of fat mass on
BMD. We found that percentage body fat was positively
related to BMD at all sites except the femur ward (p <
0.001, data not shown) when not adjusting for body weight.
When other variables including body weight were account-
ed for, this direction became opposite. Waist circumference,
which provides an indication of central obesity (visceral fat
mass), is related to radius bone mineral density in postme-
nopausal obese women, although BMI was not related to
BMD in the same study.
26,27 Our data indicate that waist
circumference (cm) is related to BMD (Table 2) and osteo-
porotic vertebral fractures (Table 3). 
Metabolic syndrome in relation to osteoporosis has been
studied. In the Rancho Bernardo Study, after adjusting for
BMI, metabolic syndrome was related to lower BMD.
28
Furthermore, the incidence of osteoporotic non-vertebral
fractures was elevated in subjects with metabolic synd-
rome (MS). Therefore, metabolic syndrome could be a
novel risk factor for osteoporosis. Accumulating evidence
suggests that individual components of metabolic synd-
rome such as hypertension, increased triglycerides, and
reduced high-density lipoprotein cholesterol are also risk
factors for low bone mineral density.
29-31 Clinical observa-
tions of diabetes patients suggest that hyperglycemia is
likely to reduce BMD and to increase the risk of osteoporo-
tic fracture.
32,33 The high vertebral fracture of diabetes pati-
ents can be explained by the fact that they are inclined to
fall due to neuropathy or retinopathy. However, we found
that serum glucose was positively correlated to lumbar,
femur neck, and femur trochanter BMD (Table 2). As we
excluded diabetic patients in our study, the average fasting
serum glucose level among participating subjects were
87.26 ± 18.81 mg/dL. This relatively low glucose level
could account for the apparently contradictory results. In
another study, serum glucose levels were also positively
related to BMD at the lumbar spine and femoral neck in
postmenopausal women with primary hyperparathyroi-
dism.
34 Further investigation is required to evaluate whe-
ther serum glucose levels have an effect on bone mineral
density and risk of fractures. 
The association between lipid profiles and BMD is also
controversial. Turkish postmenopausal women with spine
fractures had lower levels of total cholesterol, TG, and LDL-
C than patients without fractures.
35 However, another study
reported that elevated lipids, including total cholesterol and
TG, are positively related to high BMD.
36 Some studies
have demonstrated that high serum HDL is related to
lower BMD in both pre- and postmenopausal women.
37-39
Our data shows that high HDL protects against osteoporo-
sis, increasing BMD, and lowering the odds ratio of osteo-
porotic fractures (Tables 2 and 3). The mechanism by which
lipids affect BMD and the risk of osteoporotic fractures is
unclear, and needs to be investigated. The overall preval-
ence of metabolic syndrome was not related to osteopo-
rotic fractures (Table 3). 
Our study has some limitations. To demonstrate that
body composition is related to bone mineral density, body
fat mass should be analyzed as visceral fat and subcutan-
eous fat. Peripheral fat mass is not correlated to bone mine-
ral density,
40 whereas visceral fat (intra-abdominal fat)
mass might have a linkage with BMD.
41 Imaging analysis
using CT scans is also essential to evaluate the exact
distribution of visceral fat and subcutaneous fat and their
effects on bone.
41 There are possible errors to interpret the
effect of fat tissue on low bone mineral density because fat
tissue absorbs less radiation than lean tissue, so high per-
centage fat could yield a false low BMD.
42
In conclusion, high body weight and BMI are positively
related to high BMD and might decrease the risk of verteb-
ral fractures, whereas waist circumference and percentage
body fat are negatively related to BMD and might increase
the risk of vertebral fractures. Some components of meta-
bolic syndrome were related to BMD and vertebral frac-
tures. This common clinical linkage between obesity and
osteoporosis indicates that co-treatment drugs or nutrients
that can prevent and treat these chronic illnesses need to be
developed in the future.  
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